Tempest Therapeutics Inc
$ 0.90
-1.30%
06 Aug - close price
- Market Cap 14,419,800 USD
- Current Price $ 0.90
- High / Low $ 0.94 / 0.90
- Stock P/E N/A
- Book Value 0.06
- EPS -5.65
- Next Earning Report 2026-08-10
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.62 %
- ROE -7.21 %
- 52 Week High 12.23
- 52 Week Low 0.84
About
Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company is headquartered in South San Francisco, California.
Analyst Target Price
$11.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-14 | 2026-03-31 | 2025-11-05 | 2025-08-11 | 2025-05-13 | 2025-03-27 | 2024-11-12 | 2024-08-08 | 2024-05-09 | 2024-03-19 | 2023-11-08 | 2023-08-10 |
| Reported EPS | -0.5039 | -0.62 | -0.79 | -2.07 | -3.16 | -0.31 | -5.33 | -5.46 | -4.68 | -0.38 | -6.24 | -7.02 |
| Estimated EPS | -0.28 | -0.62 | -3.27 | -3.23 | -3.29 | -0.245 | -4.58 | -5.33 | -4.94 | -0.39 | -7.19 | -7.54 |
| Surprise | -0.2239 | 0 | 2.48 | 1.16 | 0.13 | -0.065 | -0.75 | -0.13 | 0.26 | 0.01 | 0.95 | 0.52 |
| Surprise Percentage | -79.9643% | 0% | 75.841% | 35.9133% | 3.9514% | -26.5306% | -16.3755% | -2.439% | 5.2632% | 2.5641% | 13.2128% | 6.8966% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-10 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.3 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
